Cold machine perfusion versus static cold storage of kidneys donated after cardiac death: A UK multicenter randomized controlled trial

American Journal of Transplantation

Volumn 10, Issue 9, 2010, Pages 1991-1999

  Watson, C J E ^a   Wells, A C ^a   Roberts, R J ^a   Akoh, J A ^b   Friend, P J ^c   Akyol, M ^d   Calder, F R ^e   Allen, J E ^f   Jones, M N ^f   Collett, D ^f   Bradley, J A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b DERRIFORD HOSPITAL   (United Kingdom)

^c CHURCHILL HOSPITAL   (United Kingdom)

^d ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^e GUY S HOSPITAL   (United Kingdom)

^f NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

Cardiac death donors; kidney preservation; kidney transplantation; machine preservation

Indexed keywords

BASILIXIMAB; MYCOPHENOLIC ACID; PREDNISOLONE; TACROLIMUS;

ADULT; ARTICLE; CLINICAL STUDY; CLINICAL TRIAL; COLD MACHINE PERFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYOPRESERVATION; DELAYED GRAFT FUNCTION; DIALYSIS; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEART DEATH; HUMAN; KIDNEY DONOR; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORGAN PERFUSION; ORGAN PRESERVATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TREATMENT OUTCOME; UNITED KINGDOM;

ACUTE DISEASE; ADULT; CRYOPRESERVATION; DEATH; DELAYED GRAFT FUNCTION; FEMALE; GRAFT REJECTION; HUMANS; INCIDENCE; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; ORGAN PRESERVATION; PERFUSION; POSTOPERATIVE PERIOD; PULSATILE FLOW; REFRIGERATION; TISSUE DONORS; TREATMENT OUTCOME;

EID: 77956165611     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03165.x     Document Type: Article

References (22)

1. Wells AC, Rushworth L, Thiru S et al. Donor kidney disease and transplant outcome for kidneys donated after cardiac death. Br J Surg 2009 96 : 299 304.
2. Yarlagadda SG, Coca SG, Formica RN, Jr., Poggio ED, Parikh CR. Association between delayed graft function and allograft and patient survival: A systematic review and meta-analysis. Nephrol Dial Transplant 2009 24 : 1039 1047.
3. Barlow AD, Metcalfe MS, Johari Y, Elwell R, Veitch PS, Nicholson ML. Case-matched comparison of long-term results of non-heart beating and heart-beating donor renal transplants. Br J Surg 2009 96 : 685 691.
4. Wight J, Chilcott J, Holmes M, Brewer N. The clinical and cost-effectiveness of pulsatile machine perfusion versus cold storage of kidneys for transplantation retrieved from heart-beating and non-heart-beating donors. Health Technol Assess 2003 7 : 1 94.
5. Moers C, Smits JM, Maathuis M-HJ et al. Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med 2009 360 : 7 19.
6. Kootstra G, Kievit JK, Heineman E. The non heart-beating donor. Br Med Bull 1997 53 : 844 853.
7. Suntharalingam C, Sharples L, Dudley C, Bradley JA, Watson CJ. Time to cardiac death after withdrawal of life-sustaining treatment in potential organ donors. Am J Transplant 2009 9 : 2157 2165.
8. Yarlagadda SG, Coca SG, Garg AX et al. Marked variation in the definition and diagnosis of delayed graft function: A systematic review. Nephrol Dial Transplant 2008 23 : 2995 3003.
9. Govani MV, Kwon O, Batiuk TD, Milgrom ML, Filo RS. Creatinine reduction ratio and 24-hour creatinine excretion on posttransplant day two: Simple and objective tools to define graft function. J Am Soc Nephrol 2002 13 : 1645 1649.
10. Rodrigo E, Ruiz JC, Pinera C et al. Creatinine reduction ratio on post-transplant day two as criterion in defining delayed graft function. Am J Transplant 2004 4 : 1163 1169.
11. Wells A, Watson C, Jamieson N, Bradley JA. Which time is it? A suggestion for unambiguous nomenclature in transplantation. Am J Transplant 2007 7 : 1315 1316.
12. Whitehead J. The design and analysis of sequential clinical trials. 2nd Ed. Chichester, UK : Wiley, 1997.
13. Orloff M, Reed A, Erturk E et al. Nonheartbeating cadaver organ donation. Ann Surg 1994 220 : 578 585.
14. Light JA, Barhyte DY, Gage FA, Sasaki TM, Aquino AO. Long-term graft survival after transplantation with kidneys from uncontrolled nonheartbeating donors. Transplantation 1999 68 : 1910 1911.
15. Port FK, Bragg-Gresham JL, Metzger RA et al. Donor characteristics associated with reduced graft survival: An approach to expanding the pool of kidney donors. Transplantation 2002 74 : 1281 1286.
16. Rosengard BR, Feng S, Alfrey EJ et al. Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donor. Am J Transplant 2002 2 : 701 711.
17. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999 130 : 461 470.
18. Hackett GH, Harris MN, Plantevin OM, Pringle HM, Garrioch DB, Avery AJ. Anaesthesia for outpatient termination of pregnancy. A comparison of two anaesthetic techniques. Br J Anaesth 1982 54 : 865 870.
19. Medical Research Council Renal Cancer Collaborators. Interferon-alpha and survival in metastatic renal carcinoma: Early results of a randomised controlled trial. Medical Research Council Renal Cancer Collaborators. Lancet 1999 353 : 14 17.
20. Storb R, Deeg HJ, Whitehead J et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 1986 314 : 729 735.
21. Novitzky D. Detrimental effects of brain death on the potential organ donor. Transplant Proc 1997 29 : 3770 3772.
22. Pirenne J, Smits JM, Moers C et al. Machine perfusion versus cold storage preservation in non-heart-beating kidney donation and transplantation; first results of a multicentre trial in Eurotransplant. Transpl Int 2009 22 (suppl 2 41 42.